Hepatology/Liver

BCLC Staging (HCC) Calculator

Free BCLC Staging Calculator for hepatocellular carcinoma. Barcelona Clinic Liver Cancer staging with integrated Child-Pugh, ECOG status, and evidence-based treatment recommendations.

References

  1. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329-338.
  2. Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol. 2022;76(3):681-693.
  3. Reig M, Forner A, Ávila MA, et al. BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update. J Hepatol. 2025.
  4. Llovet JM, Brú C, Bruix J. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 2004;10(2 Suppl 1):S115-20.
  5. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646-649.
  6. StatPearls - Use of The Child Pugh Score in Liver Disease. NCBI Bookshelf. Updated 2024.
  7. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649-655.
  8. ECOG-ACRIN Cancer Research Group. ECOG Performance Status Scale.
  9. Finn RS, Qin S, Ikeda M, et al. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med. 2020;382(20):1894-1905.
  10. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182-236.
  11. Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358-380.
  12. Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline. Hepatology. 2014;60(2):715-735.

Related calculators